Background {#Sec1}
==========

Alexander disease (AxD, OMIM 203450) is a rare but fatal central nervous system disease. Three subtypes are distinguished upon the onset age: infantile (under age 2), juvenile (age 2 to 12) and adult (over age 12). The infantile form is the most common subtype while the adult onset the least. All subtypes have been described and present with different clinical manifestations. However, the pathological hallmark of the disease is the accumulation of ubiquitinated intracytoplasmic inclusions in astrocytes, called rosenthal fibers, which are composed of glial fibrillary acidic protein (GFAP), the main intermediate filament of astrocytes \[[@CR1]\].

The adult cases can be distinguished in familial or sporadic form. Here, we present a case of adult onset AxD with family pedigree.

Case presentation {#Sec2}
=================

A 34-year-old female was evaluated at our hospital with a 6-year history of progressive neurological symptoms. At age 28, she developed paroxysmal numbness in the left limbs, and two years later she had unilateral limb weakness. She was misdiagnosed as multiple sclerosis at the other hospital 2 years after onset. After high-dose pulse methylprednisolone therapy, the illness had no mitigation. The above mentioned symptoms progressively worsened. At age 31, she subsequently developed ataxia, dysarthria, depression, and bowel and bladder urgency with occasional incontinence. And her hands became mild muscle atrophy one year later.

She denied any medical history before. Her mother had a similar neurological symptoms and died within 2 years after onset (at the age of 47), and her maternal aunt also had similar but mild symptoms at the onset age of 54 years old. Her 8-year-old daughter didn't present with any neurological symptoms but had brain lesions. Other family members were healthy (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Family pedigree. *Black filled symbols* represent patients. *Grey filled symbols* refer to patient's daughter who had GFAP mutations but without neurological signs or symptoms. *Empty symbols* represent healthy subjects. *Half-filled symbols* refer to presumably affected ancestor. *Question marks* mean subjects potentially affected without neurological signs or symptoms, not examined nor tested for GFAP mutations. *Oblique slash* means the deceased. *Black arrow mark* represents the propositus (our patient). Patient III-3 and her daughter (patient IV-4) performed the molecular diagnosis. Although the family member (II-1) had similar psychological manifestations, the detailed medical record was not obtained and not examined for GFAP mutations

Her general medical examination was unremarkable. In neurological examination, she had normal mental status and language testing. The mixed spastic-ataxic dysarthria and horizontal gaze nystagmus were noted. Myokymia was observed in lingualis with weakness of bulbar muscles. Her hands showed mild muscular atrophy. The muscles strength of the bilateral upper-extremities, the left lower-extremity, the right lower-extremity were grade 4, 2, 1, respectively. The increased tendon reflexes and the positive Babinski signs were observed bilaterally. Ataxia was observed in bilateral upper limbs. There was no apparent sensory deficit or extrapyramidal signs. The latest score of modified Rankin scale is 4.

Serum laboratory studies showed unremarkable (complete blood count, routine chemistry test, clotting studies, electrolyte panel, creatinine, glucose, liver and renal function tests, vitamin B12, vitamin E, folic acid, autoimmune antibodies, and infection including hepatitis virus antibodies, Treponema serology, HIV antibodies). Cerebrospinal fluid examination showed a normal opening pressure, the cell count, protein, glucose, IgG index, anti-aquaporin-4 antibody, and intrathecal IgG synthesis rate without oligoclonal bands.

Electroencephalogram, electrophysiological, visual evoked potential, as well as all of the autonomic nervous system testing were all normal 2 years after onset except aural conduction in their brainstem evoked potential.

Her brain MRI demonstrated bilateral and symmetric abnormal signals without gadolinium enhancement, which were predominantly distributed in the periventricular, and subcortical white matter. Diffusion Weighted Imaging (DWI) revealed slightly hyperintensity in the periventricular areas. Magnetic resonance angiography was normal \[Fig. [2](#Fig2){ref-type="fig"}\]. The marked atrophy of the medullary oblongata and thoracic spinal cord was seen, while the atrophy of cervical spinal cord was relatively mild. Abnormal T2 hyperintensity was noted in the pyramidal tract of spine. With symptoms progressively worsening, medullary and cerebellar atrophy accelerated \[Fig. [3](#Fig3){ref-type="fig"}\]. Her daughter brain MRI showed abnormality in the periventricular white matter \[Fig. [4](#Fig4){ref-type="fig"}\].Fig. 2Axial Brain MRI showed low T1-weighted signals (**a**), high T2-weighted signals (**b**), and hyperintensity in FLAIR image(**c**) around the periventricular area. MRI with contrast enhancement was normal (**d**). DWI revealed slight hyperintensity (**e**). MRA were normal (**f**) Fig. 3Axial spinal MRI showed hyperintensity involving the corticospinal tracts extends from the carotid 2 (**a** *arrowhead*) to carotid 7 cord (**b** *arrowhead*) in T2WI image, mild atrophy of cervical spinal cord in sagittal T1WI image (**c**), severe atrophy of whole thoracic segments in sagittal T2WI image, which is similar to the typical "tadpole" (**d**), medullary atrophy at 3 years after onset (**e**, **f**), and severe medulla and cerebellar atrophy 1 years later (**g**, **h**) Fig. 4Axial FLAIR image of the asymptomatic daughter of our patient show band-like hyperintense lesions around the lateral ventricle

Her genomic DNA was extracted from the peripheral leucocytes when an informed consent was obtained from the patient and her husband. A heterogeneous missense mutation was detected in exon 8 (c.1246C \> T) of the GFAP gene, causing a change of arginine to tryptophan at amino acid position 416 (p.R416W). Her daughter's genomic DNA showed the same heterozygous mutation but without any neurological symptoms \[Fig. [5](#Fig5){ref-type="fig"}\]. Upon clinical, family history, MRI finding and gene analysis, she was confirmed as adult AxD.Fig. 5The chromatograms of sequencing results. **a** The patient. **b** The daughter. **c** The control. In the area of the GFAP gene exon 8, there is a heterogeneous missense mutation point: c.1246C \> T (cytosine \> thymine, *Aarrowhead*), leading to amino acid change in p.R416W (arginine \> tryptophan)

This case with AxD is characterized by typical clinical and MRI findings, especially with family history and adult onset. The heterozygous missense mutation in the GFAP gene, c.1246C \> T, p.R416W was identified, which was already shown to be pathogenic in adult onset AxD \[[@CR2], [@CR3]\]. It has been reported that adult AxD has various clinical courses. Most cases have a subacute onset and gradually progressive course \[[@CR2]\], but some present an acute onset \[[@CR4]\]. There is no gender difference. About half of the cases is familial, consistent with autosomal dominant transmission. The mean age of onset is usually in the late thirties. Our patient had pseudobulbar, spastic paresis and ataxia, which are acknowledged as the cardinal triad of the clinical presentations and appear in approximately 70 % of cases \[[@CR2], [@CR4], [@CR5]\]. Palatal myoclonus, which is specific and essential for AxD diagnosis, is only observed in one third, especially in hereditary cases \[[@CR6]\], not seen in our patient. Nearly 45 % of reported patients had autonomic dysfunction including bowel/bladder dysfunction and orthostatic hypotension \[[@CR7]\], which was found in our patient.

Typical MRI findings included marked signal periventricular changes, atrophy of the bulbar region and upper cervical spinal cord in adult AxD \[[@CR2], [@CR7]\]. Approximately 90 % cases showed marked medullary atrophy and 50 % had deep white matter lesions or periventricular changes \[[@CR5]\]. Farina et al. reported that patients under 40 years old were easier to have periventricular white matter abnormalities and postcontrast enhancement than patients over 40, which showed different levels of abnormal diffusivity On DWI, but some cases were normal \[[@CR8]\]. In our case, MRI findings showed the severe atrophy in bulbar region and thoracic spinal cord, but mild atrophy in cervical spinal cord, which is rare in the adult AxD. On DWI, our patient had slightly hyperintensity of extensive periventricular white matter. The lesions without gadolinium enhancement might be related to the decreased amounts and limited distribution of rosenthal fibers \[[@CR8]\]. It should be stressed that MRI findings in our case was atypical despite of the lesion locating in the typical regions.

In the radiologic differential diagnosis of adult AxD, several disorders need to be considered \[[@CR9]\]. Diseases like degenerative disorders, particularly progressive supranuclear palsy, multisystem atrophy with cerebellar predominance, and various spinocerebellar ataxias often have brain stem and cerebellum atrophy but without lesions in periventricular white matter \[[@CR8]\]. Besiedes, some leukodystrophies which are similar to adult AxD were described below (see Table [1](#Tab1){ref-type="table"}) \[[@CR5], [@CR10]--[@CR17]\].Table 1The characteristics of common leukodystrophies in adultDiseaseClinical presentationAbnormal regions or abnormalities on brain MRIGene mutationsX-ALDSPCST, dorsal columns, CC, PWMABCD1Metachromatic leukodystrophyPP, motor impairmentbilateral frontal PWM, CC; cortical atrophyARSAKrabbe's disease (GALC)SP or tetraparesis, PDPN, CD, seizures, cortical blindnessSupratentorial, CWM, PT, splenium of CC and optic radiation, CST; CC atrophyGALCVWM (CACH)migraine, PP, dementia, PBP, SPenlargement of the lateral ventricles; WMEIF2BHDLS/POLDbehavioral changes, dementia, motor impairment, epilepsyinternal capsules, CST; WM with non-enhancing; frontal lobes atrophyCSF1RADLDAS, BBD, OH, PS, ataxiafrontoparietal WM, CP, CST, CCLMNB1Cerebrotendinous xanthomatosisPP, SP, CA, polyneuropathy, tendon xanthomatasdentate nucleus, CWM, CP, PT, PWN, CC, basal ganglia; brain and cerebellar atrophyCYP27A1NHD/PLOSLPP, memory loss, dementia, skeletal abnormalitiesnonspecific WM; cortical atrophyTREM2 DAP12CADASILmigraines, TIA, strokes, PP, CDPWM in the centrum semiovale, external capsules and anterior temporal polesNOTCH3CARASILTIA, strokesdiffuse WM changes, lacunar infarctsHTRA1*X-ALD* X-linked adrenoleukodystrophy, *VWM* Vanishing white matter disease, *CACH* childhood ataxia with central hypomylination, *HDLS* hereditary diffuse leukoencephalopathy with neuroaxonal spheroids, *POLD* Autosomal dominant pigmentary type of orthochromatic leucodystrophy, *ADLD* Adult-onset autosomal dominant leukodystrophy, *NHD* Nasu-Hakola disease, *PLOSL* polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy, *SP* spastic paraparesis, *PP* psychiatric problems, *PBP* pseudobulbar palsy, *WM* white matter, *CWM* cerebellar WM, *PT* pyramidal tracts, *CD* cognitive decline, *AS* autonomic symptoms, *BBD* bowel and bladder dysfunction, *OH* orthostatic hypotension, *PS* pyramidal symptoms, *CA* cerebellar ataxia, *TIA* transient ischemic attacks, *PDPN* peripheral demyelinating polyneuropathy, *CST* corticospinal tracts, *CC* corpus callosum, *PWM* periventricular WM, *CP* cerebellar peduncles

Beside, asymptomatic carriers with MRI abnormalities have been described in some reports \[[@CR2], [@CR6], [@CR8], [@CR18]--[@CR23]\]. Here we listed several asymptomatic carriers similar to our patient's daughter who had abnormal brain MRI and carrying the gene mutation (see Table [2](#Tab2){ref-type="table"}).Table 2The information of asymptomatic carriers with MRI abnormalitiesPatient ReferenceGenderAge (years)MRI scanNucleotide changeAminoacid substitutionPatient 1 \[[@CR18]\]Male62Mild cervicomedullary atrophyc.232G \> Ap.D78NPatient 2 \[[@CR6]\]Male32Atrophy of medulla oblongata and spinal cord, Periventricular rimc. 274 T \> Gp.V87GPatient 3 \[[@CR19]\]Male33Atrophy of medulla oblongata and spinal cord, white matter lesion, periventricular rimc. 274 T \> Gp.V87GPatient 4 \[[@CR20]\]Male^a^\<4Frontal white matter abnormalityc.276C \> Tp.R88CPatient 5 \[[@CR2]\]Male30Supratentorial periventricular white matter, atrophy of medulla oblongata and cervical cordc.613G \> Ap.E205KPatient 6 \[[@CR21]\]Male32Periventricular rim, atrophy of medullac.988C \> Gp.R330Gc.994G \> Ap.E332KPatient 7 \[[@CR22]\]Female34Mild abnormal intensities in the deep frontal white matter and caudatesc.1006 T \> Cp.L331PPatient 8 \[[@CR23]\]Male72Atrophy of the upper cervical cord medullaoblongata and cerebellarc.1157A \> Gp.N386SPatient 9 \[[@CR8]\]Male52Supratentorial periventricular white matter, atrophy of medulla oblongata and cervical cordc. 1193C \> Ap.S398YPatient 10 \[[@CR20]\]Male^a^\<11White matter of the cerebellum, medulla, pons changesc.1260C \> Tp.R416Wc.154C \> Tp.P47L^a^No age at onset is reported for Patients 4 and 10; evaluation for leukodystrophy was initiated only after incidental findings of white matter changes were discovered by MRI performed as part of examination for other conditions

Mutations in the GFAP gene, which lead to the accumulation of ubiquitinated intracytoplasmic inclusions in rosenthal fibers in association with the small heat shock proteins, HSP27 and aB-crystallin \[[@CR1]\], are thought to account for more than 95 % of AxD cases \[[@CR24]\]. In infantile \[[@CR3], [@CR25], [@CR26]\], juvenile \[[@CR20], [@CR27]\] and sporadic adult AxD \[[@CR28]--[@CR30]\], the heterozygous missense mutation of the GFAP gene, c.1246C \> T, p.R416W, has been reported to be one of the causes of AxD. While In familial adult onset AxD it has been rarely reported. Thyagarajan described a woman and her son with adult onset AxD and the above mutation \[[@CR31]\]. They had different clinical manifestations but strikingly similar MRI abnormalities and the same GFAP mutation. It means that molecularly characterized inherited AxD is a cause of symptoms. The same GFAP mutation can cause both early and late onset AxD, and vertical transmission occurs in adult onset AxD with GFAP mutations. Our patient, her mother and maternal aunt had similar neurological manifestations but the latter two had a relative later onset. Nevertheless, her mother's clinical manifestations deteriorated rapidly, her maternal aunt has mild symptoms with comparatively slow progress. She and her daughter had the same heterozygous missense mutation. All these findings suggest that the familial Adult AxD members can possibly show either similar or different manifestations. The molecular genetic evidence of our AxD family favors that AxD is an autosomal dominant inheritance \[[@CR32]\], but further long-term follow-up is needed.

Conclusions {#Sec3}
===========

In summary, our case report enriches the understanding of the familial adult AxD. Genetic analysis is necessary when patients have the above mentioned symptoms and signs, MRI findings, especially with family history.
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